Market Tracker

02/11 2:15pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

56.68
BATS BZX Real-Time Price
As of 2:14pm ET
 -0.32 / -0.56%
Today’s Change
53.26
Today|||52-Week Range
140.00
-39.79%
Year-to-Date

Today’s Trading

Previous close57.00
Today’s open55.60
Day’s range53.26 - 57.45
Volume758,595
Average volume (3 months)958,685
Market cap$4.8B
Dividend yield--
Data as of 2:14pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+31.23%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book4.70

Competitors

 Today’s
change
Today’s
% change
IONSIonis Pharmaceutical...+0.71+2.15%
ICLRICON PLC-1.27-1.91%
CRLCharles River Labora...-1.57-2.18%
PRXLPAREXEL Internationa...-0.43-0.74%
Data as of 2:14pm ET, 02/11/2016

Financials

Next reporting dateFebruary 12, 2016
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts